Clinical Trials · NCT02778919
Late Phase II Clinical Study of KLH-2109 in Patients With Endometriosis
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Enrollment
- 0
- Start date
- May 2016
- Locations
- 1 site, Japan
- Primary endpoint
- Change of average Numerical Rating Scale (NRS) score of pelvic pain